CardioGenics Holdings (CardioGenics Holdings) Interest Expense : $-0.44 Mil (TTM As of Jan. 2016)

View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. CardioGenics Holdings's interest expense for the three months ended in Jan. 2016 was $ -0.13 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jan. 2016 was $-0.44 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. CardioGenics Holdings's Operating Income for the three months ended in Jan. 2016 was $ -0.20 Mil. CardioGenics Holdings's Interest Expense for the three months ended in Jan. 2016 was $ -0.13 Mil. CardioGenics Holdings did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CardioGenics Holdings Interest Expense Historical Data

The historical data trend for CardioGenics Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings Interest Expense Chart

CardioGenics Holdings Annual Data

Trend

Jul06

Jul07

Jul08

Oct09

Oct10

Oct11

Oct12

Oct13

Oct14

Oct15

Interest Expense

Get a 7-Day Free Trial

-0.02

-0.30

-1.84

-0.48

CardioGenics Holdings Quarterly Data
	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Jul15	Oct15	Jan16
Interest Expense	Get a 7-Day Free Trial															-0.16	-0.10	-0.13	-0.08	-0.13

CardioGenics Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jan. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.44 Mil.

CardioGenics Holdings (OTCPK:CGNH) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CardioGenics Holdings's Interest Expense for the three months ended in Jan. 2016 was $-0.13 Mil. Its Operating Income for the three months ended in Jan. 2016 was $-0.20 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jan. 2016 was $0.00 Mil.

CardioGenics Holdings's Interest Coverage for the quarter that ended in Jan. 2016 is calculated as

CardioGenics Holdings did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

CardioGenics Holdings (CardioGenics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8

Website

http://www.cardiogenics.com

CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines